VentriPoint Diagnostics Ltd. – TSX:VPT.V
VentriPoint Diagnostics Ltd. stock price today
VentriPoint Diagnostics Ltd. stock price monthly change
VentriPoint Diagnostics Ltd. stock price quarterly change
VentriPoint Diagnostics Ltd. stock price yearly change
VentriPoint Diagnostics Ltd. key metrics
Market Cap | 47.07M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.03 |
Revenue | N/A |
EBITDA | -4.59M |
Income | -4.71M |
Revenue Q/Q | -100% |
Revenue Y/Y | -4.55% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeVentriPoint Diagnostics Ltd. stock price history
VentriPoint Diagnostics Ltd. stock forecast
VentriPoint Diagnostics Ltd. financial statements
| Jun 2023 | 3.89K | -1.11M | -28661.09% |
|---|---|---|---|
| Sep 2023 | 0 | -1.17M | |
| Dec 2023 | 41.40K | -1.23M | -2988.05% |
| Mar 2024 | 0 | -1.18M |
| Jun 2023 | 3886490 | 1.49M | 38.51% |
|---|---|---|---|
| Sep 2023 | 2916470 | 1.60M | 54.94% |
| Dec 2023 | 1883385 | 1.69M | 89.93% |
| Mar 2024 | 853647 | 1.77M | 208.11% |
| Jun 2023 | -945.30K | 0 | -32.11K |
|---|---|---|---|
| Sep 2023 | -970.22K | 0 | -26.68K |
| Dec 2023 | -991.77K | 0 | -29.39K |
| Mar 2024 | -873.25K | 0 | -31.77K |
VentriPoint Diagnostics Ltd. other data
-
What's the price of VentriPoint Diagnostics Ltd. stock today?
One share of VentriPoint Diagnostics Ltd. stock can currently be purchased for approximately $0.28.
-
When is VentriPoint Diagnostics Ltd.'s next earnings date?
Unfortunately, VentriPoint Diagnostics Ltd.'s (VPT.V) next earnings date is currently unknown.
-
Does VentriPoint Diagnostics Ltd. pay dividends?
No, VentriPoint Diagnostics Ltd. does not pay dividends.
-
How much money does VentriPoint Diagnostics Ltd. make?
VentriPoint Diagnostics Ltd. has a market capitalization of 47.07M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 27.85% to 49.18K US dollars.
-
What is VentriPoint Diagnostics Ltd.'s stock symbol?
VentriPoint Diagnostics Ltd. is traded on the TSX under the ticker symbol "VPT.V".
-
What is VentriPoint Diagnostics Ltd.'s primary industry?
Company operates in the Healthcare sector and Medical Devices industry.
-
How do i buy shares of VentriPoint Diagnostics Ltd.?
Shares of VentriPoint Diagnostics Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When VentriPoint Diagnostics Ltd. went public?
VentriPoint Diagnostics Ltd. is publicly traded company for more then 17 years since IPO on 26 Sep 2007.
-
What is VentriPoint Diagnostics Ltd.'s official website?
The official website for VentriPoint Diagnostics Ltd. is ventripoint.com.
-
Where are VentriPoint Diagnostics Ltd.'s headquarters?
VentriPoint Diagnostics Ltd. is headquartered at 18 Hook Avenue, Toronto, ON.
-
How can i contact VentriPoint Diagnostics Ltd.?
VentriPoint Diagnostics Ltd.'s mailing address is 18 Hook Avenue, Toronto, ON.
VentriPoint Diagnostics Ltd. company profile:
VentriPoint Diagnostics Ltd.
ventripoint.comTSX
0
Medical Devices
Healthcare
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.
Toronto, ON M6P 1T4
:
ISIN: CA92281P2008
:
